by The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn or Million in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The pituitary cancer market consists of drugs and devices used in the diagnosis and treatment of pituitary cancers. Pituitary cancer is a rare type of tumor that develops in the pituitary gland located at the base of the brain. Symptoms include headaches, vision problems, and hormonal issues. Diagnosis involves imaging tests like MRI and CT scan to detect the size and location of the tumor. Surgery is the primary treatment to remove the tumor followed by radiation therapy and medication. Drugs like cabergoline and bromocriptine are used to manage hormonal excess caused by pituitary tumors.
Market key trends:
The key trend in the pituitary cancer market is growing research into combination therapies. Traditional treatments like surgery and radiation have limitations and risks. Researchers are exploring combining targeted drug therapies with other treatments for improved outcomes. Some clinical trials are evaluating combinations of chemotherapy with radiation or targeted drugs. Advancements in genetic testing is another area of focus. Understanding the specific molecular makeup of individual tumors can help guide customized treatment approaches. Development of novel targeted drugs attacking specific cancer pathways also holds potential. Overall, a combination of advanced diagnostics and personalized multi-modal treatments promise better management of this rare form of cancer.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is low as pituitary cancer industry requires huge capital investments and stringent regulatory environment.
Bargaining power of buyers: The bargaining power of buyers is moderate as the existing treatment options are limited and patients have less choice but the demand is low due to low incidence of cancer.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as key raw materials include complex biological ingredients and require specialized R&D capabilities.
Threat of new substitutes: The threat of new substitutes is low as there are limited treatment alternatives available for pituitary cancer currently.
Competitive rivalry: High due to presence of large pharmaceutical companies.
Key Takeaways
The global Pituitary Cancer Market Growth is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period 2023 to 2030, due to increasing incidence of pituitary cancer worldwide. According to statistics, the pituitary cancer affects 1 person per 10 million people worldwide each year and results in over 2,000 new cases diagnosed in the United States annually.
Regional analysis: North America is expected to dominate the global pituitary cancer market over the forecast period. This is attributed to the increasing adoption of advanced treatment options and presence of prominent players in the region. Europe is also anticipated to exhibit a steady growth rate during the forecast period owing to improving healthcare infrastructure and rising healthcare spending.
Key players operating in the pituitary cancer market are Novartis International AG, Pfizer Inc., Merck & Co., Inc., Ipsen Biopharmaceuticals, Inc., Bayer AG, Novo Nordisk A/S, Eli Lilly and Company, Bristol Myers Squibb Company, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Sanofi SA, AstraZeneca PLC, Eisai Co., Ltd., Janssen Pharmaceuticals, Inc. (Johnson & Johnson). Key players are majorly focusing on new product launches and acquisitions to strengthen their market position.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.
